1. UICC International Union Against Cancer: Sobin LH, Gospodarowicz MK, Wittekind Ch. // In: TNM classification of malignant tumours. 7th edition. Chichester: Wiley-Blackwell. 2009:138-46.
2. Billiet C, Peeters S, Decaluwé H, et al. Postoperative radiotherapy for lung cancer: Is it worth the controversy? Cancer Treat Rev. 2016;51:417-25.
3. Vansteenkiste J, De Ruysscher D, Eberhardt WE, et al. ESMO Guidelines Working Group. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):89-98.
4. De Ruysscher D, Belderbos J, Reymen B, et al. State of the art radiation therapy for lung cancer 2012: a glimpse of the future. Clin Lung Cancer. 2013;14(2):89-95.
5. Solodky VA, Sotnikov VM, Trotsenko SD, et al. Characteristics of recurrences after surgical and combined treatment of non-small cell lung cancer. Problems in Onkology. 2017;63(4):639-44.
6. Matthews MJ, Kanhouwa S, Pickren J, Robinette D. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer. Cancer Chemother Rep. 1973;(4)2:63-7.
7. Kharchenko VP, Chkhikvadze VD, Gvarishvili AA, Vasilyev OA. Surgical and combined treatment of non-small cell lung cancer. Vestnik RUDN. Seria Medicina. 2005;29(1):13-16.
8. Varlotto JM, Yao AN, DeCamp MM, et al. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival. Int J Radiat Oncol Biol Phys. 2015;91(4):765-73.
9. Robinson CG, Patel AP, Bradley JD, et al. Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base. J Clin Oncol. 2015;33(8):870-6.
10. Su S, Scott WJ, Allen MS, et al. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial. J Thorac Cardiovasc Surg. 2014;147(2):747-52.
11. Kharchenko VP, Chkhikvadze VD. Surgical and combined treatment of non-small cell lung cancer. Problems in Onkology. 2009;55(4):455-8.
12. Shen W, Ji J, Zuo Y, et al. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial. Radiotherapy and Oncology. 2014;110(1):120-5.
13. Warren M, Webster G, Ryder D, et al. An isotoxic planning comparison study for stage II-III non-small cell lung cancer: is intensity-modulated radiotherapy the answer? Clinical Oncology. 2014;26(8):461-7.



